This report shows how biopharmaceutical research companies continue to be vitally important to the economy and patient health in Oregon.

Since 2004, biopharmaceutical research companies have conducted or are conducting more than 5,600 clinical trials of new medicines in Oregon in collaboration with clinical research centers, hospitals, and local research institutions. These clinical trials have investigated or are investigating some of Oregon’s biggest health care challenges, including asthma, arthritis, cancer, infectious diseases, cardiovascular disease and gastrointestinal diseases.

“Biopharmaceutical research companies have been and continue to be a good source of high-paying jobs, tax revenue and research spending in Oregon. These companies also support the jobs of their vendors, construction, local restaurants, day care centers and other community businesses. But first and foremost, we’re here for our patients. Helping patients and ensuring their safety is our profession’s top priority. There is no doubt that all Oregonians benefit from this industry and its innovations.”  Curt A. Heiting, President of Cyn3rgy Research and Development